TEK and acute lymphoblastic leukemia: To further study the role of ZEB2 as a putative oncogene in the pathogenesis of T-ALL, we crossed our recently developed conditional ROSA26-based Zeb2 gain-of-function mouse model18 with the Tie2-Cre line19.